150 related articles for article (PubMed ID: 10980653)
1. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
[No Abstract] [Full Text] [Related]
2. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
[No Abstract] [Full Text] [Related]
3. Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.
Segawa F; Shimizu Y; Saito E; Kinoshita M
J Rheumatol; 1995 Jun; 22(6):1183-4. PubMed ID: 7674251
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
Ariad S; Song E; Cohen R; Bezwoda WR
Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
6. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
8. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
[No Abstract] [Full Text] [Related]
9. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
[No Abstract] [Full Text] [Related]
10. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
11. [Complete cytogenetic response to interferon-alpha in a patient with chronic myelogenous leukemia undergoing hemodialysis].
Doi S; Edamura S; Akasaka H; Kawamura M; Arima N; Nasu K
Rinsho Ketsueki; 2001 Jul; 42(7):549-53. PubMed ID: 11524845
[TBL] [Abstract][Full Text] [Related]
12. Major depression and psoriasis activation due to interferon-alpha in a patient with chronic myeloid leukemia; "overlooked and/or misdiagnosed adverse reaction in malignant disease".
Besisik SK; Kocabey G; Caliskan Y
Am J Hematol; 2003 Nov; 74(3):224. PubMed ID: 14587060
[No Abstract] [Full Text] [Related]
13. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
[No Abstract] [Full Text] [Related]
14. [Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia].
Uehara E; Uesugi T; Tasaka T; Matsuhashi Y; Tamura T; Kuwajima M; Nagai M
Gan To Kagaku Ryoho; 2002 Feb; 29(2):317-21. PubMed ID: 11865642
[TBL] [Abstract][Full Text] [Related]
15. 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
Mehta ND; Hooberman AL; Vokes EE; Neeley S; Cotler S
Am J Hematol; 1992 Oct; 41(2):141. PubMed ID: 1415177
[No Abstract] [Full Text] [Related]
16. [Occurrence of autoimmune complications in patients with chronic myelocytic leukemia during treatment with interferon alfa].
Tóthová E; Stecová N; Kafková A; Fricová M; Svorcová E
Vnitr Lek; 2002 May; 48(5):380-3. PubMed ID: 12061203
[TBL] [Abstract][Full Text] [Related]
17. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
Ladoyanni E; Nambi R
J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
[TBL] [Abstract][Full Text] [Related]
19. Interferon-associated retinopathy.
Savant V; Gillow T
Eye (Lond); 2003 May; 17(4):534-6. PubMed ID: 12802361
[No Abstract] [Full Text] [Related]
20. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
